Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ATORVASTATIN Cause Post procedural haemorrhage? 26 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Post procedural haemorrhage have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.0% of all adverse event reports for ATORVASTATIN.

26
Reports of Post procedural haemorrhage with ATORVASTATIN
0.0%
of all ATORVASTATIN reports
13
Deaths
14
Hospitalizations

How Dangerous Is Post procedural haemorrhage From ATORVASTATIN?

Of the 26 reports, 13 (50.0%) resulted in death, 14 (53.8%) required hospitalization, and 13 (50.0%) were considered life-threatening.

Is Post procedural haemorrhage Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 26 reports have been filed with the FAERS database.

What Other Side Effects Does ATORVASTATIN Cause?

Type 2 diabetes mellitus (7,556) Myalgia (7,155) Drug hypersensitivity (3,929) Drug ineffective (3,865) Fatigue (3,439) Arthralgia (3,338) Rhabdomyolysis (3,286) Dyspnoea (3,137) Nausea (2,888) Asthenia (2,791)

What Other Drugs Cause Post procedural haemorrhage?

LEVONORGESTREL (1,106) RIVAROXABAN (930) ASPIRIN (618) APIXABAN (539) ADALIMUMAB (476) IBRUTINIB (269) CLOPIDOGREL BISULFATE (235) HEPARIN (174) WARFARIN (170) DABIGATRAN ETEXILATE (121)

Which ATORVASTATIN Alternatives Have Lower Post procedural haemorrhage Risk?

ATORVASTATIN vs ATORVASTATIN\EZETIMIBE ATORVASTATIN vs ATOSIBAN ATORVASTATIN vs ATOVAQUONE ATORVASTATIN vs ATOVAQUONE\PROGUANIL ATORVASTATIN vs ATRACURIUM

Related Pages

ATORVASTATIN Full Profile All Post procedural haemorrhage Reports All Drugs Causing Post procedural haemorrhage ATORVASTATIN Demographics